Form 4: Avanos Medical: Director Receives Restricted Share Units

Indrani Lall Franchini, a Director at Avanos Medical, Inc., was granted 12,003 restricted share units on May 8, 2026, replacing previous units.

Summary

• Indrani Lall Franchini, a Director of Avanos Medical, Inc., was issued 12,003 restricted share units (RSUs) on May 8, 2026.
• These RSUs represent a contingent right to receive a cash payment equivalent to the value of one share of Avanos Medical's common stock.
• The issuance of these RSUs replaces previously issued RSUs from January 2, 2025.
• The RSUs will vest upon the Reporting Person's termination of service on the Issuer's Board of Directors.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation event for a director rather than a significant strategic or financial development.

Positives

• Director Indrani Lall Franchini has been granted a significant number of restricted share units, indicating continued incentive and alignment with the company's performance.
• The replacement of previous RSUs suggests a continuation of the incentive plan and a commitment to retaining key leadership.

Risks

• The value of the restricted share units is tied to the future stock price of Avanos Medical, meaning their ultimate value is subject to market fluctuations and company performance.
• Vesting is contingent upon termination of service, which could be viewed as a retention mechanism but also implies a potential future departure.

Future Outlook

The future outlook for the value of the restricted share units is dependent on the performance of Avanos Medical's common stock, which will be realized upon the vesting of these units.

Industry Context

StockSavvy.ai notes that the issuance of restricted share units to directors is a common practice in the healthcare technology sector to align executive interests with shareholder value and to attract and retain talent.

Stakeholder Impact

• Shareholders: The issuance of RSUs is a form of compensation and dilution, but also aims to align director interests with long-term shareholder value.
• Employees: Indirectly impacted by director compensation structures and the company's ability to retain key leadership.
• Management: The grant of RSUs reinforces the incentive structure for leadership.

Next Steps

• Vesting of restricted share units upon termination of service on the Board of Directors.

Key Dates

Keywords

Avanos Medical, AVNS, Form 4, Insider Trading, Restricted Share Units, RSU, Director Compensation, Securities Exchange Act, Beneficial Ownership